S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)
S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)
S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)
S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)

Virpax Pharmaceuticals (VRPX) SEC Filings & 10K Form

Notice: Trading of Virpax Pharmaceuticals halted at 09:35 AM EST due to "LULD pause".
$3.55
+0.50 (+16.44%)
(As of 01:28 PM ET)

Recent Virpax Pharmaceuticals SEC Filings

DateFilerForm TypeView
01/31/2024
3:22 PM
Floyd Eric (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:22 PM
Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:23 PM
Sendrow Jerrold (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:23 PM
Dubin Michael F (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:24 PM
Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:25 PM
Jambulingam Thani (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:25 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:26 PM
Singh Vanila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
9:11 AM
SABBY MANAGEMENT, LLC (Filed by)
Virpax Pharmaceuticals (Subject)
Form SC 13G/A
12/29/2023
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
7:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
7:58 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
8:08 AM
Virpax Pharmaceuticals (Filer)
Form DEF 14A
12/07/2023
7:50 AM
Virpax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/17/2023
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
6:15 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
3:51 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
2:03 PM
Virpax Pharmaceuticals (Filer)
Form NT 10-Q
10/11/2023
3:10 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
8:51 AM
Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2023
8:28 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
4:00 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4/A
08/16/2023
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
8:05 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
8:15 AM
Virpax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2023
7:14 AM
Virpax Pharmaceuticals (Filer)
Form DEFA14A
06/21/2023
3:16 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:17 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2023
3:18 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2023
8:00 PM
Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2023
7:00 PM
Ruskin Barbara (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2023
7:05 PM
Ruskin Barbara (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2023
3:06 PM
Virpax Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2023
8:00 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2023
8:11 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VRPX) was last updated on 3/1/2024 by MarketBeat.com Staff